NEUROENDOCRINE NEOPLASM

Clinical trials for NEUROENDOCRINE NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE NEOPLASM trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 8 Completed 1

Immunotherapy-Radiation combo shows promise in tough lung cancer

Disease control Completed

This early-phase trial tested the safety and best dose of the immunotherapy drug pembrolizumab when combined with chemotherapy and radiation for people with small cell lung cancer. The goal was to see if adding pembrolizumab helps the immune system fight the cancer more effective…

Matched conditions: NEUROENDOCRINE NEOPLASM

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC

NEUROENDOCRINE NEOPLASM

Get alerted when new NEUROENDOCRINE NEOPLASM trials appear

Immunotherapy-Radiation combo shows promise in tough lung cancer